Emotion Clinical Trial
Official title:
Pilot Study Assessing Cognitive Function and Emotional Possessing in Patients With Bilateral Facial Palsy
Verified date | June 2014 |
Source | Medical University of Vienna |
Contact | n/a |
Is FDA regulated | No |
Health authority | Austria: Ethikkommission |
Study type | Observational |
Based on recent findings that botulinum toxin injections in the cranial muscles might reduce
emotional processing (Havas 2011), an increasing number of popular newspaper tabloids are
suggesting a negative effect on cognition. The underlying research articles address the
"facial feedback hypothesis". The hypothesis indicates that expressive behaviour, including
facial mimic expressions influences the subject's brain via feedback. (Alam 2008) Other
systemic neurological diseases, e.g of inflammatory origin, may lead to temporary bilateral
facial nerve palsy (BF). During recovery process, the palsy usually remits completely.
The effect of bilateral facial muscle palsy on cognition and emotional possessing has never
been evaluated.
The results of this pilot study might provide new information about the effect bilateral
facial palsy on emotional processing and cognition and the facial feedback hypothesis.
The aim of this controlled pilot study is to assess cognitive function and emotional
processing in patients with bilateral facial palsy. In addition, differences in cognitive
function and emotional processing in patients with different manifestations of dystonia
should be evaluated.
According to the facial feedback theory, paralysed mimic muscles might alter emotional
processing. Therefore, investigators compare patients with bilateral facial muscle palsy and
healthy controls. Investigators expect no influence of facial muscle palsy on cognitive
functions in any of the tested groups; the investigators expect a mild impairment of
emotional processing only in the patients group with bilateral facial muscle palsy (BEB and
BF). In addition, the investigators expect no difference in emotional processing in patients
with different manifestations of dystonia (BEB and CD) at remission. There might be a slight
difference of emotional processing in patients with different manifestations of dystonia
(BEB and CD) at time of prominent facial palsy.
Status | Completed |
Enrollment | 84 |
Est. completion date | December 2013 |
Est. primary completion date | May 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: Patients: - willing to participate in this pilot trial - bilateral facial palsy - age 18-80 years Control: - willing to participate in this pilot trial - age, - gender and - education (duration of school attendance) matched - and/or cervical dystonia Exclusion Criteria: - neurological or psychiatric comorbidity - psychotropic drugs |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Austria | Department of Neurology, Medical University of Vienna | Vienna |
Lead Sponsor | Collaborator |
---|---|
Kirsten Elwischger, MD |
Austria,
Alam M, Barrett KC, Hodapp RM, Arndt KA. Botulinum toxin and the facial feedback hypothesis: can looking better make you feel happier? J Am Acad Dermatol. 2008 Jun;58(6):1061-72. doi: 10.1016/j.jaad.2007.10.649. Review. — View Citation
Havas DA, Glenberg AM, Gutowski KA, Lucarelli MJ, Davidson RJ. Cosmetic use of botulinum toxin-a affects processing of emotional language. Psychol Sci. 2010 Jul;21(7):895-900. doi: 10.1177/0956797610374742. Epub 2010 Jun 14. — View Citation
Hennenlotter A, Dresel C, Castrop F, Ceballos-Baumann AO, Wohlschläger AM, Haslinger B. The link between facial feedback and neural activity within central circuitries of emotion--new insights from botulinum toxin-induced denervation of frown muscles. Cereb Cortex. 2009 Mar;19(3):537-42. doi: 10.1093/cercor/bhn104. Epub 2008 Jun 17. Erratum in: Cereb Cortex. 2010 Jan;20(1):253. Baumann, Andres O Ceballos [corrected to Ceballos-Baumann, Andres O]. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | I-S-T-2000R- (intelligence-structure-test 2000R) | Test to evaluate Intelligence Subtest "Matrixes" Subtest "Analogies" |
up to four weeks | No |
Secondary | Beck's depression-inventory-II | Evaluation of depression (BDI-II; Hautzinger et al., 2009) | up to four weeks | No |
Secondary | Apathy Evaluation Scale | Evaluation of apathy (AES; Luecken et al., 2006) | up to four weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02194907 -
Emotion Study -- A Neurofeedback Approach
|
N/A | |
Recruiting |
NCT03554694 -
Gut-brain Axis, Brain Function, and Behaviour.
|
N/A | |
Recruiting |
NCT03085628 -
Sex- and Context-dependent Effects of Oxytocin on Social Reward Processing
|
N/A | |
Completed |
NCT03688048 -
Effects of a Single Dose of Bright Light Treatment on Measures of Affective Information Processing
|
N/A | |
Completed |
NCT02839395 -
The Effects of Acute vs. Chronic of Screen Illumination on: Sleep Efficacy and Architecture, Physiology, Emotion and Behavior: Possible Effect on Human Health
|
N/A | |
Completed |
NCT02219620 -
Examining the Effects of (MiM) Treatment on Emotional and Cognitive Functioning of Residents in Long-term Care
|
N/A | |
Completed |
NCT03623477 -
Can Cognitive Training Decrease Reactive Aggression?
|
N/A | |
Completed |
NCT02301715 -
Effects of Intranasal Oxytocin on Emotion Regulation in Adolescents
|
Phase 1 |